Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more) Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

Avivagen Announces Further Swine Trial Agreement With National Institute of Animal Sciences for Vietnam

TheNewsWire October 26, 2015

Avivagen Announces First Results of Poultry Trial With Institute of Agro-food Research and Technology of Catalonia

TheNewsWire October 22, 2015

Avivagen's Vivamune(tm)Vital Health3 Chews Now Available to U.S. Pet Retailers Unique supplement with OxC-beta(tm) benefits immune system, skin, joint and digestive health for dogs and cats.

TheNewsWire September 1, 2015

Avivagen Announces Stock Option Grant

TheNewsWire August 20, 2015

Avivagen Announces Poultry Trial Agreement with Institute of Agro-food Research and Technology of Catalonia

TheNewsWire August 10, 2015

Avivagen Announces Attendance At The 2015 VetHealth Global Conference

TheNewsWire June 9, 2015

Avivagen Announces Conversion of a Liability to Equity and the Grant of Options

TheNewsWire May 19, 2015

Avivagen Announces Two Appointments to its Board of Directors, Mr. David Allan and Ms. Vanessa Grant

TheNewsWire May 14, 2015

Avivagen Announces Presentation at Bloom Burton & Co. Conference on May 4, 2015

TheNewsWire May 1, 2015

Avivagen Announces Abstract Presentation of Final Poultry Trial Results at Symposium of the Korean Society of Veterinary Science

TheNewsWire April 29, 2015

Avivagen Announces CEO Update

TheNewsWire April 16, 2015

Avivagen Summarizes Final Aquaculture Trial Results

TheNewsWire April 10, 2015

Avivagen Announces Publication of an Opinion-Editorial In Ottawa's "The Hill Times" Newspaper

TheNewsWire March 30, 2015

Avivagen Announces Launch of New Consumer-Friendly E-Commerce Website

TheNewsWire March 23, 2015

Avivagen Announces Voting Results for the Election of its Directors

TheNewsWire March 13, 2015

Avivagen Summarizes Final Poultry Trial Results

TheNewsWire March 3, 2015

Avivagen & Bayer Terminate U.S. Distribution Agreement for Oximunol Chewable Tablets

TheNewsWire February 16, 2015

Avivagen Summarizes Final Swine Trial Results

TheNewsWire February 11, 2015

Avivagen Provides Update Regarding Proof of Concept Work On Permanent Non-Surgical Sterilization

TheNewsWire February 3, 2015

Avivagen Announces Attendance at AlphaNorth Capital Conference January 16 & 17, 2015

TheNewsWire January 16, 2015